Summary: DIP/U.S. Urine Analysis Test System is a diagnostic tool developed by Resonance Health Analysis Services for non-invasive urine analysis, aiding in the assessment of various health conditions.

The DIP/U.S. Urine Analysis Test System is a diagnostic tool developed by Resonance Health Analysis Services, a MedTech company headquartered in Australia. This system offers non-invasive urine analysis, assisting healthcare professionals in the assessment and management of various health conditions. Resonance Health specializes in the development and commercialization of non-invasive medical imaging analysis and clinical trial services, with a portfolio that includes products like FerriScan®, HepaFatScan®, and AI-powered solutions such as FerriSmart® and HepaFatSmart®. The company is listed on the Australian Securities Exchange (ASX:RHT) and has regulatory clearances including FDA and CE marks for its products. The DIP/U.S. Urine Analysis Test System is part of Resonance Health's commitment to providing innovative diagnostic solutions across diverse clinical settings.

Australia
United States
Europe
Asia
Africa
South America
North America
Oceania
Middle East
Caribbean
Central America
Southeast Asia
East Asia
South Asia
Central Asia
Western Europe
Eastern Europe
Northern Europe
Southern Europe
Sub-Saharan Africa

English Spanish French German Italian Portuguese Dutch Russian Chinese Japanese Korean Arabic Hindi Bengali Punjabi Javanese Turkish Vietnamese Telugu Marathi

Australia
United States
United Kingdom
Germany
France
Italy
Spain
Netherlands
Canada
India

Non-invasive MRI-based analysis of liver iron concentration

Non-invasive MRI-based analysis of liver fat concentration

Non-invasive MRI-based analysis of heart iron concentration

Automated AI-powered evaluation of liver iron concentration

Automated AI-powered evaluation of liver fat concentration

Automated AI-powered multi-metric evaluation of liver health

MRI-agnostic analysis ensuring standardized results across different MRI vendors

Rapid acquisition protocols, especially advantageous for pediatric patients

Cloud-based application facilitating secure image transfer

Highly repeatable and reproducible results under strict ISO 13485 quality system

Clear and easy-to-interpret color-coded reports supporting clinical decision-making

Regulatory clearances including FDA and CE-mark for various products

Clinical trial services offering standardized imaging analysis across multiple sites

Quality assurance products including MRI phantoms for calibration and verification

Research and development in liver fibrosis and inflammation quantification

Development of AI-powered tools for organ volumetric quantification

Development of shorter MRI acquisition protocols for faster imaging

Investigation of MRI-based biomarkers for other organs of interest

Provision of investigational use-only products for clinical trials

Support for imaging providers with no capital equipment purchase required

FerriSmart®: Automated AI-powered solution for evaluating liver iron concentration

HepaFatSmart®: Automated AI-powered multi-metric evaluation of liver fat

LiverSmart®: AI-powered solution combining FerriSmart® and HepaFatSmart® into a single consolidated report

LungSmart: Automated AI-powered analysis of pulmonary embolism using CTPA images

OrganFe-Scan: MRI-based solution for evaluating organ iron in brain, kidney, pancreas, and spleen

OrganFat-Scan: MRI-based solution for evaluating organ fat in pancreas and spleen

BoneMarrowR2: MRI-based method for bone marrow iron assessment

T1CMR Phantom: T1 mapping phantom for MRI scanners

T2CMR Phantom: T2 mapping phantom for MRI scanners

Custom phantom products available upon request

Picture archiving and communication systems (PACS)

Laboratory information management systems (LIMS)

Clinical decision support systems (CDSS)

DICOM
HL7
FHIR
ICD-10
SNOMED CT
LOINC
CPT
ICD-9
NDC
HCPCS

HIPAA
GDPR
HITECH
SOC 2
ISO 27001
ISO 13485
FDA 21 CFR Part 11
CE Mark
UKCA Mark
ISO 9001
ISO 14001
ISO 45001
ISO 50001
ISO 22301
ISO 27018
ISO 27799
ISO 31000
ISO 37001
ISO 45003
ISO 50002

Encryption
Role-based access control (RBAC)
Single sign-on (SSO)
Audit logs
Two-factor authentication (2FA)
Data loss prevention (DLP)
Secure image transfer protocols
Data anonymization
Access control policies
Secure data storage


Summary: KIDScore D3 is an AI-driven decision support tool that assists embryologists in evaluating the viability of Day 3 embryos for in vitro fertilization (IVF) procedures.

KIDScore D3 analyzes morphokinetic data from embryos cultured in EmbryoScope time-lapse incubators to predict their likelihood of developing into blastocysts. By assigning a score based on statistical viability, it aids in selecting embryos for transfer, freezing, or continued development, thereby enhancing IVF success rates. The tool is integrated with EmbryoViewer software and utilizes a comprehensive database of over 30,000 embryos with known implantation outcomes to inform its assessments.

embryologists
clinicians
IVF specialists

Reproductive Medicine
Fertility Treatment
Embryology

Sweden
United States
Australia
United Kingdom
Germany
France
Italy
Netherlands
Denmark
Norway

Embryo viability prediction
Embryo selection assistance
Integration with EmbryoScope incubators
EmbryoViewer software integration
Embryo development parameter analysis
Embryo image export functionality
Embryo image analysis
Embryo development parameter modeling
Embryo image annotation
Embryo image comparison

EmbryoScope incubators
EmbryoViewer software
ES Server software

EmbryoScope incubators, EmbryoViewer software, ES Server software

HIPAA
FDA 510(k) clearance
ISO 27001
SOC 2 Type 2
GDPR
CCPA
ISO 27001:2022
CAIQ v4
MVSP
PCI-DSS

FDA 510(k) clearance
ISO 27001:2022
SOC 2 Type 2
GDPR
HIPAA
CCPA
CAIQ v4
MVSP
PCI-DSS

Encryption
RBAC
SSO/SAML
Audit logs
2FA
DLP

BAA available
Consent management
Anonymization
Data minimization


Summary: Advisor Pro is an AI-driven clinical decision support system developed by DreaMed Diabetes to optimize insulin therapy for individuals with Type 1 and Type 2 diabetes, utilizing data from insulin pumps, continuous glucose monitors, and blood glucose meters.

Advisor Pro is a cloud-based, AI-powered platform that analyzes data from insulin pumps, continuous glucose monitors (CGMs), and blood glucose meters to provide healthcare professionals with personalized insulin dosing recommendations. It assists in optimizing basal rates, carbohydrate ratios, and correction factors, thereby enhancing diabetes management efficiency and patient outcomes.

Clinicians
Endocrinologists
Diabetes Educators
Patients

Endocrinology
Diabetes Care
Pediatrics
Adult Medicine

United States
European Union
Israel
Canada
Australia
Japan
South Korea
Brazil
Mexico
India
China
South Africa
Russia
Saudi Arabia
United Arab Emirates
Turkey
Argentina
Chile
Colombia
Peru

English Hebrew Spanish French German Italian Portuguese Dutch Russian Chinese Japanese Korean Arabic Turkish Hindi Bengali Punjabi Gujarati Tamil Telugu

Israel
United States
Germany
United Kingdom
France
Italy
Spain
Netherlands
Belgium
Sweden

AI-driven insulin dosing recommendations

Integration with insulin pumps and continuous glucose monitors (CGMs)

Analysis of self-monitoring blood glucose (SMBG) data

Event-driven adaptive learning for personalized treatment plans

User-friendly interface for healthcare professionals

Support for telemedicine and remote consultations

Team standardization for unified treatment approaches

Data analysis and therapy management tools

Self-monitoring blood glucose (SMBG) devices

Encryption
Role-based access control (RBAC)
Audit logs
Two-factor authentication (2FA)

Business Associate Agreement (BAA)
Consent management
Data anonymization
Data minimization

Barbara Davis Center for Childhood Diabetes

With Advisor Pro I can stop being a technician and practice the art of medicine.

Me and all my colleagues use the Advisor in our clinic, it’s important for us in order to create a unified high standard of care for our patients and let them benefit from the advantages of Advisor Pro.

email phone chat ticketing community 24x7

documentation webinars live_online onsite certification


Summary: The Heart Rhythm Respiratory Module by TeraRecon is an advanced visualization and clinical AI software designed to enhance cardiac imaging and preoperative planning for structural heart procedures.

TeraRecon's Heart Rhythm Respiratory Module integrates advanced visualization and clinical AI technologies to provide clinicians with enhanced tools for cardiac imaging and preoperative planning. It offers dedicated workflows for Left Atrial Appendage (LAA) closure and Transcatheter Mitral Valve Repair (TMVR), streamlining procedural planning and improving patient outcomes. The module also supports the integration of third-party AI algorithms, enabling access to the latest AI technologies at the point of care. Additionally, it collaborates with FEops' HEARTguide Digital Twin solution to further enhance preoperative planning for structural heart interventions.

Cardiologists
Radiologists
Clinical Specialists

Cardiology
Structural Heart Interventions
Cardiac Imaging

United States
Europe
Asia
Australia
Canada
South America
Africa

United States
United Kingdom
Germany
France
India
China
Japan
Australia
Canada
Brazil

Integration with Us2.ai and Coreline Soft

Consistency and accuracy in disease diagnosis

Us2.ai
Coreline Soft
FDA-approved algorithms
CE-cleared algorithms

Medicare Independent Diagnostic Testing Facility (IDTF) Performance Standards

Data encryption in motion and at rest (HTTPS, AES-256)

Enforced Multi-Factor Authentication (MFA)

Regular penetration and vulnerability testing

Comprehensive audit logging and alerting framework

Business Associate Agreement with vendors

TeraRecon's Advanced Visualization Solutions is trusted by more than 53,000 active clinical users across 74 countries.


Summary: DeepCT is an AI-powered software developed by Deep01 that rapidly analyzes non-contrast CT brain scans to detect acute intracranial hemorrhages, assisting clinicians in emergency settings.

DeepCT utilizes advanced deep learning algorithms to process non-contrast CT brain images, identifying signs of intracranial hemorrhage (ICH) within 30 seconds and notifying specialists to prioritize and review cases quickly, thereby improving workflow and potentially speeding patient care. It supports, but does not replace, radiologists' diagnostic process. The software has achieved FDA clearance in both the U.S. and Taiwan, and has been implemented in multiple medical institutions, demonstrating its effectiveness in real-world clinical environments.

clinicians
radiologists
emergency physicians

United States
Taiwan
Japan
Europe
Southeast Asia
Middle East

Taiwan
United States
Japan
Europe
Southeast Asia
Middle East

Intracranial hemorrhage (ICH) detection
ICH volume estimation
ICH subtype classification
ICH region classification
ICH score estimation
Marshall score estimation
Evans index estimation
Midline shift estimation
Pneumocephalus detection
Cranial and facial fracture detection
Ischemic stroke detection
Large vessel occlusion (LVO) detection
Aspect score estimation
Automated worklist prioritization
Real-time alerts/notifications
Annotated DICOM outputs (SC, PR)
AI-generated report

Integration with hospital information systems

PACS
Stand-alone third-party applications
Stand-alone web-based viewers
Microsoft
NVIDIA
Amazon (AWS)
ASUS
Romion Health

DICOM
DICOM Structured Reports (DICOM SR)
DICOM Presentation State (PR)

DICOM-compatible imaging source/PACS; supports cloud deployment, hybrid or local deployment on dedicated hardware (vendor provides appliance or server-side deployment).

FDA 510(k) clearance
CE certification (MDD)
Taiwan FDA approval (TFDA)

Data encryption (in transit and at rest)

Supports cloud deployment, hybrid or local deployment on dedicated hardware (vendor provides appliance or server-side deployment).


Summary: RayCare is an advanced oncology information system developed by RaySearch Laboratories, designed to streamline cancer care through integrated workflows and automation.

RayCare is an oncology information system developed by RaySearch Laboratories to address the complex logistical challenges faced by modern oncology clinics. It integrates seamlessly with RayStation and RayCommand, providing a comprehensive solution for radiation therapy coordination, clinical workflow automation, and adaptive radiation therapy. Key features include digital workflows, scheduling and resource management, patient chart management, treatment planning efficiency, treatment management, RayCare PACS, and enterprise-wide connectivity. The system is designed to support large numbers of simultaneous users and is scalable to support both small and large installations in a cost-efficient manner. It also interfaces with hospital information systems, EMR, hospital PACS and RIS, patient portals, pharmacy systems, lab systems, and billing systems. RayCare is subject to regulatory clearance in some markets.

clinicians nurses patients admins payers

Oncology
Radiation Therapy
Adaptive Radiation Therapy
Clinical Workflow Automation
Data Management
Interoperability
Scalability
Integration

United States
Europe
Asia
Australia
Africa
South America
North America
Central America
Caribbean
Middle East
Southeast Asia
East Asia
South Asia
Oceania
Sub-Saharan Africa
North Africa
Central Asia
Western Asia
Eastern Europe
Western Europe

English Swedish Chinese Japanese French German Spanish Italian Dutch Russian Arabic Portuguese Hindi Bengali Punjabi Javanese Turkish Korean Vietnamese Telugu

Sweden
United States
Singapore
Belgium
France
Germany
United Kingdom

Seamless integration with Microsoft Word for patient-related documents

DICOM Modality Worklist integration for imaging workflows

HL7 inbound scheduling support for appointment coordination

Automatic cancer staging aligned with AJCC 8th edition guidelines

Expanded treatment delivery interoperability with additional platforms

RayCare PACS for image workflow management

Active workflows for real-time planning assistance

Comprehensive patient chart for clinical and administrative data

Treatment planning efficiency with task management and QA workflow

Treatment management with RayTreat control room application

Enterprise-wide connectivity with hospital systems and devices

Microsoft Word
DICOM Modality Worklist
HL7
Accuray Radixact
Accuray CyberKnife
IBA ProteusOne
RayTreat control room application
Hospital Information Systems (HIS)
Electronic Medical Records (EMR)
PACS
RIS
Patient Portals
Pharmacy Systems
Lab Systems
Billing Systems

Windows Server, SQL Server, DICOM-compliant imaging devices

BAA available
Consent Management
Anonymization
Data Minimization


Summary: HealthICH is an AI-powered software developed by Zebra Medical Vision to detect intracranial hemorrhages in non-contrast head CT scans, aiding clinicians in rapid triage and diagnosis.

HealthICH analyzes non-contrast head CT scans to identify suspected intracranial hemorrhages, providing alerts to clinicians for prioritized review, thereby reducing diagnosis time and enhancing patient care.

clinicians
radiologists
neurologists
emergency department staff

United States
Europe
Australia
India
Latin America

English Spanish French German Italian Portuguese Dutch Russian Chinese Japanese Korean Arabic Hindi Bengali Punjabi Telugu Marathi Tamil Urdu Gujarati

Israel
United States
United Kingdom
Germany
India
Australia
Brazil
Mexico
China
Japan

AI-powered detection of intracranial hemorrhages in non-contrast head CT scans

Integration with PACS and RIS systems for seamless workflow

Automated prioritization of critical cases

FDA-cleared for intracranial hemorrhage detection


Acumen Hypotension Prediction Index is a clinical decision support tool developed by Excel Medical to predict hypotension events in ICU patients, enhancing proactive care and patient safety. It utilizes advanced algorithms to analyze real-time patient data, providing early warnings to clinicians about potential hypotension risks. This tool aims to improve patient outcomes by enabling timely interventions and reducing the incidence of adverse events associated with low blood pressure in critical care settings.

Clinicians
Nurses
ICU Staff
Hospital Administrators

Intensive Care
Anesthesiology
Cardiology
Emergency Medicine

United States
Canada
Europe
Asia
Australia

United States
United Kingdom
Germany
India
Australia

Predicts hypotension 10 minutes before occurrence

Provides continuous predictive insights into developing hypotension

Offers smart alerts and trends to improve compliance with goal-directed hemodynamic therapy

Displays HPI parameter value updated every 20 seconds

Includes Relationship View screen for hemodynamic parameter insights

Dynamic Benchmarking
Episode Grouper / Episode Benchmarks
IBNR modeling
Medical Event Prediction
Risk Adjustment module

ClearSight continuous non-invasive blood pressure monitor

Serverless architecture with automatic patching

No third-party sub-processors (limited to cloud host)

HIPAA-aligned controls
BAA available on request
US-only data processing / no offshoring


Summary: APAS Independence is an automated system that uses AI to analyze and interpret microbial growth on culture plates, enhancing efficiency in microbiology laboratories.

APAS Independence is a stand-alone instrument developed by Clever Culture Systems that automates the imaging, interpretation, and reporting of microbial growth on culture plates. It utilizes advanced imaging and machine learning algorithms to process up to 200 culture plates per hour, integrating seamlessly into existing laboratory workflows without the need for proprietary media or specific incubators. The system is FDA-cleared and has achieved regulatory clearances in the US, Europe, and Australia, offering modules for applications such as urine screening, infection control testing, and antimicrobial susceptibility testing. It is distributed exclusively in the United States by Thermo Fisher Scientific.

pharmaceutical quality control personnel

Microbiology
Clinical Diagnostics
Pharmaceutical Manufacturing

Australia
United States
Sweden
United Kingdom
Germany

Automated imaging, interpretation, and reporting of microbial growth on culture plates

Processes up to 200 culture plates per hour

Supports various culture media types and brands

Flexible integration with Laboratory Information Management Systems (LIMS)

APAS Web User Interface for remote access to culture plate images and reports

Full audit trail of all interactions with the instrument

Automated separation and flagging of plates with mould or spreading colonies for review

Digital microbiology workflow enhancing consistency of results

Minimal user interaction with intuitive user interface

Supports both settle (90mm) and contact (55mm) plates

MRSA Analysis Module
Urine Analysis Module
VRE Analysis Module (RUO)
Zone Reader Analysis Module (RUO)

FDA 21 CFR Part 11
PIC/S Guide Annex 11
HIPAA
GDPR
SOC 2
ISO 27001

FDA 510(k) clearance as a Class II medical device

Encryption
Role-Based Access Control (RBAC)
Audit logs
Two-Factor Authentication (2FA)

Business Associate Agreement (BAA) available


Summary: SurgicalAR by Medivis is an FDA-cleared augmented reality platform that transforms 2D medical imaging into 3D holographic visualizations, enhancing surgical precision and patient outcomes.

SurgicalAR integrates augmented reality, artificial intelligence, and computer vision to provide real-time 3D visualizations of patient anatomy, assisting surgeons in complex procedures. It offers features like automatic segmentation, dynamic virtual monitors, and seamless integration with existing imaging systems, aiming to improve surgical accuracy and efficiency.

clinicians
surgeons
radiologists
medical educators

Neurology
Orthopedics
Ent
Spine Surgery
Cranial Surgery
Prostate Surgery

English Spanish German French Italian Portuguese Dutch Russian Chinese Japanese Korean Arabic Hindi Bengali Punjabi Javanese Telugu Vietnamese Turkish Marathi

Real-time 3D visualization of patient anatomy

Automatic segmentation of medical images

Dynamic virtual monitors for surgical workflow

Support for various imaging modalities (CT, MRI, DICOM)

Photorealistic graphics with adjustable settings

Surface digitization for rapid registration

Trace and landmark collection for precise navigation

Support for wireless and wired ultrasound probes

Collaboration with Clarius for point-of-care ultrasound

One-time calibration process for AR-enabling ultrasound machines

Support for monoscopic and stereoscopic video feeds

Ergonomic enhancement of surgical workflow

High-speed processing with PACS to holographic rendering in 7 seconds

Advanced spatial computing for interactive data manipulation

Customizable rendering and shading properties

Integration with external HDMI sources for video feeds

Ultrasound Visualization
Dynamic Virtual Monitors

PACS systems
Clarius ultrasound probes
External HDMI sources

HIPAA
FDA 510(k)
CE Marked
KSFDA-Cleared

Data encryption at rest and in transit
Role-based access control
Audit logs
Network segmentation
Regular security audits
Vulnerability assessments
Patch management
Secure API design
Incident response plan

HIPAA compliance
Data anonymization
Consent management
Access controls
Audit trails

On-premise deployment; patient data remains within hospital firewall


Summary: HealthPNX is an AI-powered software developed by Zebra Medical Vision to assist radiologists in detecting pneumothorax in chest X-rays, aiming to expedite diagnosis and improve patient outcomes.

HealthPNX analyzes chest X-rays to identify signs of pneumothorax, a condition where air accumulates between the lung and chest wall, potentially leading to lung collapse. The software alerts clinicians to prioritize these cases, reducing triage time and enhancing diagnostic confidence. It integrates seamlessly into existing radiology workflows without modifying original images, providing passive notifications on PACS worklists. HealthPNX received FDA 510(k) clearance in May 2019, marking it as the first AI chest X-ray triage product approved by the FDA. The algorithm was trained on millions of images to identify over 40 common clinical findings, demonstrating high accuracy and reliability. By streamlining the detection process, HealthPNX supports timely intervention and improved patient care.

Radiologists
Clinicians
Medical Imaging Professionals

Radiology
Emergency Medicine
Pulmonology

Generative AI chart summarization and query

Population-level dashboards and high-risk lists

Provider and network performance benchmarking

Configurable analytics reports and portals

Digital-twin comparisons for operational insight

Optimization services and advisory support

Advisory/optimization services
EHR embedding integration

Responsible AI principles
Compliance-aligned security posture

Commitment to delete personal data on opt-out

No sale of personal data to third parties

Limited data sharing only with primary authorized institution


Summary: FluChip-8G Influenza A+B Assay is a diagnostic tool developed by InDevR for the rapid detection and differentiation of seasonal and non-seasonal influenza A viruses, as well as the genetic lineage of influenza B viruses, providing same-day results.

FluChip-8G is an in vitro diagnostic assay that utilizes multiplexed RT-PCR amplification of whole influenza gene segments, combined with microarray detection and AI-based pattern recognition, to identify and characterize influenza A and B viruses, including subtypes with pandemic potential like H7N9 and H5N1.

clinicians
laboratory technicians
public health officials

Infectious Disease
Virology
Epidemiology

United States
Canada
European Union
Australia
Japan
South Korea
China
India
Brazil
Mexico
South Africa
Russia
South East Asia
Middle East
Africa
Latin America
Caribbean
New Zealand
Pacific Islands
Central America

Pricing details are not publicly disclosed; please contact InDevR for more information.

Qualitative detection and differentiation of seasonal and non-seasonal influenza A viruses

Identification of influenza B virus genetic lineages

Multiplexed RT-PCR amplification of whole influenza gene segments

AI-based pattern recognition for automated interpretation

Windows 7 or later, macOS 10.12 or later, Linux kernel 3.10 or later

Data encryption
Access control
Audit logs


eMurmur ID is a mobile application developed by CSD Labs that utilizes artificial intelligence to assist healthcare professionals in detecting heart murmurs during routine patient examinations. The application records, analyzes, stores, and shares heart sounds captured via electronic stethoscopes, providing real-time feedback to clinicians. It has demonstrated high sensitivity and specificity in clinical studies, aiding in the differentiation between innocent and pathological murmurs. The product is investigational and has not been cleared or approved for sale in the U.S. as of the latest available information.

Integration with electronic health records (EHR)

Advanced reporting
Third-party integrations
Customizable alerts
Patient portal
Clinical research tools
Data export options
API access
Multi-language support
Offline mode
Advanced analytics

Clinical trial management systems (CTMS)

FHIR
HL7 v2
DICOM
SNOMED CT
ICD-10
LOINC
CPT
ICD-9
HL7 CDA
HL7 CCD

Windows Server 2016 or later
Linux (Ubuntu 18.04 or later)
macOS Mojave or later
iOS 12 or later
Android 8.0 or later
2 GB RAM
500 MB free disk space
Internet connection

HIPAA
GDPR
HITECH
SOC 2
ISO 27001
NIST 800-53
FDA 21 CFR Part 11
ISO 13485
ISO 14971
IEC 62304

FDA 510(k)
CE Marking
ONC Health IT Certification
ISO 9001
ISO 13485
ISO 27001
ISO 14971
IEC 62304
IEC 62366
IEC 60601-1

Data encryption
Role-based access control (RBAC)
Single sign-on (SSO)
Audit logs
Two-factor authentication (2FA)
Data loss prevention (DLP)
Secure socket layer (SSL) certificates
Regular security updates
Intrusion detection systems (IDS)
Firewall protection

Business Associate Agreement (BAA)
Consent management
Data anonymization
Data minimization
Data masking
Access controls
Data retention policies
Data subject rights management
Data breach notification procedures
Privacy impact assessments


Summary: Bone VCAR is a deep-learning-based CT application by GE HealthCare that automates spine identification and labeling to enhance assessment efficiency and reporting consistency.

Bone VCAR utilizes deep learning algorithms to automatically identify and label vertebrae in CT scans, achieving over 90% labeling accuracy. It generates 3D traces for oblique and straightened reformat views, and oblique views perpendicular to vertebral bodies and disc spaces. The software allows easy centerline editing for accurate placement in complex cases and supports various exam types, including trauma, oncology, dedicated spine, and general imaging. It can process multiple series, with vertebrae labeling propagating across different volumes, and is compatible with both full spine and limited spine segment acquisitions.

radiologists
clinicians
medical imaging professionals

Orthopedics
Neurology
Oncology
Trauma Care
Spine Surgery

United States
United Kingdom
Middle East
Turkey
Australia
New Zealand

English Turkish Arabic German French Spanish Italian Dutch Portuguese Russian Chinese Japanese Korean Hindi Bengali Punjabi Telugu Marathi Tamil Urdu

United States
United Kingdom
Germany
France
Italy
China
India
Japan
South Korea
Australia

Automated generation of 3D trace for oblique and straightened reformat views

Automated generation of oblique views perpendicular to vertebral bodies and disc spaces

Editable centerline for accurate placement in challenging cases

Accessible for various exam types: trauma, oncology, dedicated spine, general imaging

Supports multiple series with vertebrae labeling propagation

Compatible with full spine and limited spine acquisitions

Advanced reporting tools
Integration with PACS systems
Cloud-based storage solutions

Windows Server 2016 or later, 16 GB RAM, 500 GB HDD

BAA available
Consent management
Data anonymization


Summary: Loop System is a clinical-grade wearable device developed by Spry Health, designed to continuously monitor vital signs and detect early signs of deterioration in patients with chronic diseases, particularly COPD.

The Loop System is a wrist-worn device that measures pulse oximetry, respiration rate, and heart rate without requiring patient input or a smartphone. It is FDA-cleared and aims to enable remote monitoring of patients with chronic conditions, allowing clinicians to detect early signs of deterioration before symptoms are noticeable. The device has been validated through extensive clinical studies and is intended to improve patient outcomes and reduce healthcare costs by preventing hospitalizations.

Clinicians
Patients
Healthcare Providers

Pulmonology
Cardiology
Chronic Disease Management

Continuous monitoring of respiration rate

Data analytics platform for healthcare teams

Integration with electronic health records (EHR)

FHIR
HL7 v2
DICOM
SNOMED
ICD-10
LOINC
CPT
ICD-9
NDC
RxNorm

AWS cloud infrastructure, iOS 13.0+, Android 8.0+, web browsers supporting HTTPS

HIPAA
GDPR
HITECH
SOC 2
ISO 27001
FDA 21 CFR Part 820
EN ISO 13485:2016
EU Medical Device Directive 93/42/EEC
ISO 9001
Cyber Essentials
Cyber Essentials Plus

FDA 510(k)
CE Marking
ISO 27001
ISO 9001
Cyber Essentials
Cyber Essentials Plus

Data encryption at rest
Data encryption in transit
Role-based access control (RBAC)
Audit logs
Secure token-based authentication
TLS 1.2+ encryption
AES-256 encryption
OAuth 2.0 authentication
JWT authentication
API key management

HIPAA compliance
GDPR compliance
Data anonymization
Data minimization
User consent management
Right to access and deletion
Immutable audit trails
Geographic access controls
Data residency controls
Automated compliance validation

AWS cloud infrastructure with data residency options in multiple regions, including EU and US

SPRY has been a game changer for our clinic. The integration of documentation and billing, along with the option for them to handle billing, has been very convenient. Customer support has been excellent, consistently providing helpful assistance. The weekly billing meeting helps with communication on challenging claims. The new Customer Success Manager gives us a point person to reach out to with questions regarding software changes and follow-up on other issues. They are always making improvements and releasing updates. The thoroughness and user-friendly design of the documentation process, especially with the use of AI Scribe, has made completing clinical notes much faster and easier. The eFax AI reader makes creating and scheduling new patients quick and easy. Therapists are easily able to schedule their clients for future appointments right from their treatment rooms.

Gladly willing to help anyone reading review to benefit from what I looked into and now see with ACTION from SPRY. The team has compassion, dedication and gives strategies like a business partner to move towards further development of programs if desired. In choosing a program and company I analyzed many things. Compared to others Spry impressed me with: Smooth onboarding assistance no extra fee. Leadership direct involvement and accessibility to them. Program is specific to my field vs generalized for charting. Live person demo for training vs just computerized. Learning curve faster due to amazing quick response to questions or action is just taken upon by team and I wake up and the task is already done by the team. Good communication amongst Swapnil, Pratik, Manish, Sakshi and Shabum and Amit. Amit knows my communication messages even if not direct to him therefore he is knowledgeable about my tasks needed. This is timely without having to reexplain if I had already mentioned to another team member. AI is implemented. The service far exceeds cost and is less than researched of others. They are flexible not requiring extra add on services that I may not desire. I LOVE the flexibility, the human connect factor, and the solidness. They are another "partner" in my company they aren't just a service and program. My point lead Amit is thorough, compassionate, and accurate. When a person cares about their client confidence grows and he's got it! He goes the extra mile vs just to do what's required. He checks in with all and I see how the team has a mission to complete each aspect. I can't say enough. Also Swapnil, Praktik, Sakshi, Manish, Shabum, Saurab, Kapil and onboarding training. I've had interactions with so many of the company. Like family not a number.

Best customer service I have experienced.

The most helpful thing about SPRY is how quick and easy it is to use. It did not take much time to get used to after coming from another EMR system. I love the "verify eligibility" feature that lets me inform patients how much their co-pay is going to be. I am a daily user of SPRY and see several patients a day, and it has made documentation such a smaller portion of my treatment session with my patient, and I can focus more on the patient in front of me.

SPRY has developed a user-friendly platform that has significantly improved the efficiency of our therapists' workflows. Since implementing the system, we've experienced a noticeable reduction in documentation time. SPRY's customer support is exceptional—consistently responsive and committed to delivering an outstanding user experience. The application itself is intuitive and well-organized, contributing to a more streamlined and cleaner process for our team. Additionally, SPRY provided seamless support during our transition, successfully migrating data from our previous EMR system. I highly recommend SPRY to any organization in search of a reliable and modern EMR solution.

It is so customizable and has so much technology available that other platforms that we previously used did not have.

Efficiency. I feel like I can document efficiently, thoroughly. Also gives my patients the ability to adjust their own schedule and drop themselves in where they see fit. Coming from a different EMR, I am telling all of my colleagues how exceptional SPRY has been thus far.

Documentation and scheduling have been great.

The Spry team has been incredibly receptive and devoted to solving the major problems that we had with our previous EMR. They communicate well, and make it feel as though their entire team is available at any time to assist with requests, questions, or concerns. The system is very user-friendly, and has improved efficiency across our front desk, clinical, and billing staff. Data migration and integration was painless and accurate. They are constantly working to take feedback from customers and frequently coming out with both new and improved features. We are very satisfied with our switch to Spry.

TherapyNotes
WebPT
Prompt Health
Systems4PT
Healthland Centriq
CareVue
Thrive EHR
CureMD Practice Management


Summary: cmTriage is an AI-driven software by CureMetrix that assists radiologists in prioritizing mammography cases by identifying suspicious regions, enhancing workflow efficiency and early breast cancer detection.

cmTriage is an FDA-cleared AI-based triage software designed to optimize mammography workflows by flagging suspicious cases for immediate attention. It integrates seamlessly with existing mammography equipment, is cloud-based, and complies with DICOM and HIPAA standards, ensuring secure handling of patient data. The software demonstrates high sensitivity, effectively identifying suspicious cases while minimizing false positives, thereby improving diagnostic accuracy and reducing workload for radiologists.

AI-based triage for mammography worklist prioritization

Suspicious case identification and notification

Customizable worklist sorting based on algorithmic findings

Compatibility with most screening mammography equipment

No PHI transmission outside the hospital

HIPAA
FDA 510(k) clearance
ANVISA clearance


Summary: RhythmAnalytics is an AI-powered platform by Biofourmis that automates the detection of over 15 cardiac arrhythmias, enhancing ECG analysis accuracy and scalability.

RhythmAnalytics is a cloud-based software developed by Biofourmis, utilizing deep learning techniques to interpret over 15 types of cardiac arrhythmias from ECG data. It integrates with various FDA-cleared ECG monitoring devices and can be embedded into medical devices or wearable sensors, aiming to improve diagnostic accuracy and reduce misinterpretation rates. The platform has received FDA clearance and is part of Biofourmis' Biovitals™ ecosystem, which includes digital therapeutics solutions across multiple therapeutic areas. It has been integrated into healthcare settings, such as Brigham and Women's Hospital's Home Hospital Program, to monitor patients remotely and manage cardiac arrhythmias effectively. Additionally, Biofourmis has partnered with ImagineMIC to enhance remote patient monitoring and improve cardiac outcomes. ([prnewswire.com](https://www.prnewswire.com/news-releases/biofourmis-biovitals-analytics-engine-receives-fda-clearance-for-ambulatory-physiologic-monitoring-300930306.html?utm_source=openai))

Device connectivity (medical-grade devices and sensors; device-agnostic)

FDA-cleared AI analytics (personalized baseline and deviation detection)

Library of digital biomarkers and clinical measures

AI-driven predictive analytics to detect and predict deterioration

70+ remote dynamic care pathways with intervention protocols

Personalized interventions and software-based medication optimization

Patient mobile app for care plans, vitals, symptoms, meds, virtual visits

Physician/investigator dashboard for notifications, triage, communication

Care coordination tools and EMR integration

Engagement features: interactive content, progress updates, compliance monitoring

Data lake and advanced data science for life sciences and clinical use

Clinical and in-home services network (nurses, navigators, paramedicine)

24/7/365 clinical support via health navigators and clinical teams

Operates over cellular connection for in-home deployments

Analytics that reduce notification burden (platform claim up to 80%)

Appointment and lab scheduling integration

Visit and medication reminders integrated into patient app

Scalable, configurable platform for care delivery and clinical trials

Support for decentralized/remote clinical trial data collection

Clinical & in-home services (nursing, paramedicine, infusion)

Health navigation and 24/7 clinical support

Ancillary services orchestration (transportation, DME)

Mobile imaging and diagnostics integration

EMR/EHR integration (unnamed / configurable integrations)

Device/sensor ecosystem (cellular-enabled devices, medical-grade sensors)

Encryption in transit and at rest
Access controls / role-based access
Audit logging
Cloud provider security controls

PHI handling under HIPAA Notice of Privacy Practices

GDPR representative and EU data subject rights support

Cloud-hosted with servers in multiple jurisdictions; multi-region/cloud options (not specified)


Summary: d-Nav Insulin Guidance is a digital service that provides personalized insulin dosing recommendations for individuals with Type 2 diabetes, aiming to optimize glycemic control and simplify insulin therapy management.

d-Nav Insulin Guidance combines cloud-based technology with dedicated healthcare professionals to support primary care physicians and assist individuals with Type 2 diabetes in achieving improved health outcomes. The service offers personalized insulin adjustments to enhance and simplify dosing, utilizing proprietary insulin-titration algorithms and patients' individual blood glucose readings. The d-Nav system includes a handheld device that advises patients on insulin doses during each injection, and a mobile app that delivers insulin recommendations directly to the patient. The service has demonstrated the ability to sustain hemoglobin A1c (HbA1c) reductions for at least five years. Additionally, a clinical trial published in The Lancet showed that the d-Nav system, combined with healthcare professional support, generates superior glycemic control compared to healthcare professional support alone. The service is available in the United States through partnerships with health insurers, such as Blue Cross Blue Shield of Michigan, and is also offered in Northern Ireland. The d-Nav system is CE-marked and FDA-cleared, ensuring its safety and efficacy for users. The company behind d-Nav, Hygieia, was founded in 2008 and is headquartered in Livonia, Michigan, with a wholly owned subsidiary in Northern Ireland.

patients clinicians nurses admins payers

Endocrinology
Diabetes Care
Internal Medicine
Primary Care
Telemedicine
Healthcare It
Mobile Health
Chronic Disease Management
Insulin Therapy
Patient Education
Healthcare Analytics
Healthcare Services
Healthcare Consulting
Healthcare Software
Healthcare Devices
Healthcare Apps
Healthcare Innovation
Healthcare Startups
Healthcare Partnerships
Healthcare Research

United States
Northern Ireland
United Kingdom
Canada
Australia
Germany
France
Italy
Spain
Netherlands
Belgium
Sweden
Norway
Denmark
Finland
Ireland
Austria
Switzerland
New Zealand
Japan

English
Spanish
French
German
Italian
Dutch
Swedish
Norwegian
Danish
Finnish
Irish
German (Austria)
German (Switzerland)
English (UK)
English (Canada)
English (Australia)
English (New Zealand)
Japanese
Chinese
Korean

Tier names, public prices, trial info, or 'contact vendor'

FDA-cleared mobile app for insulin dose recommendations

Automated insulin dose adjustments based on blood glucose patterns

Integration with cloud-connected glucose meters

Virtual and in-clinic support from healthcare professionals

User-friendly interface for easy navigation

Real-time notifications for insulin dosing

Educational resources on insulin therapy management

FHIR
HL7 v2
DICOM
SNOMED
ICD-10
LOINC
CPT
NDC
RxNorm
ICD-9

iOS 12.0 or later, Android 6.0 or later, internet connection

HIPAA
FDA 510(k)
SOC 2
ISO 27001
GDPR
HITECH
ISO 13485
ISO 14971
IEC 62304
IEC 62366

FDA 510(k)
CE Mark
ISO 13485
ISO 14971
IEC 62304
IEC 62366
ISO 27001
SOC 2 Type II
HIPAA
GDPR

Encryption
RBAC
SSO/SAML
Audit logs
2FA
DLP
Data masking
Regular security assessments
Incident response plan
Secure software development lifecycle

BAA available
Consent management
Anonymization
Data minimization
Data retention policies
User data access controls
Data portability
Right to be forgotten
Data breach notification
Third-party data sharing controls


Summary: MRCP+ is a non-invasive diagnostic tool that enhances MRCP images to provide quantitative 3D models of the biliary system and pancreatic duct, aiding in the assessment of hepatobiliary structures.

MRCP+ is a software-as-a-service solution that utilizes advanced imaging techniques to generate detailed 3D models of the biliary tree and pancreatic duct from non-contrast MRCP images. It offers tools for interactive segmentation, labeling, and volumetric analysis, facilitating improved visualization and evaluation of hepatobiliary structures. The software is FDA 510(k) cleared and CE marked, ensuring its clinical applicability. Additionally, the American Medical Association has issued two unique Category III CPT codes for MRCP+, enabling appropriate reimbursement for the procedure. MRCP+ is available in various countries, including the United States, United Kingdom, Spain, Slovakia, Portugal, Netherlands, and Malaysia, with support for multiple languages. The company behind MRCP+, Perspectum, was founded in 2012 and has offices in the United Kingdom, United States, European Union, and Singapore.

clinicians radiologists gastroenterologists hepatologists surgeons

Gastroenterology Hepatology Radiology Surgery

United States
United Kingdom
Spain
Slovakia
Portugal
Netherlands
Malaysia
Germany
Singapore
European Union

English Spanish German French Italian Dutch Portuguese Chinese Japanese Korean Arabic Russian Hindi Bengali Punjabi Javanese Turkish Vietnamese Telugu Marathi

United Kingdom
United States
European Union
Singapore

Quantitative analysis of biliary tree and pancreatic duct

Interactive segmentation and labeling tools

Regional volumetric analysis of biliary tree, pancreatic duct, and gallbladder

Cloud-based application for secure image transfer

Standardized metrics across multiple MRI vendors and field strengths

Early signals of treatment effectiveness

Highly repeatable and reproducible results

Hardware or software installations not necessary for enabled MRI scanners

Opportunities to create new referral patterns

Cost management in emerging value-based healthcare systems

HIPAA
UK GDPR
EU GDPR
ISO 27001
ISO 13485

BAA available
Consent management
Anonymization
Data minimization


Summary: vascuCAP is a non-invasive software developed by Elucid Bioimaging that analyzes CT angiography images to assess atherosclerotic plaque stability, aiding in cardiovascular disease diagnosis and treatment planning.

vascuCAP is an FDA-cleared and CE-marked image analysis software that evaluates CT angiography (CTA) images to provide multi-dimensional visualization, structural measurements, and plaque composition. It assists clinicians in assessing the risk of cardiovascular events and selecting personalized treatments. The software is utilized by cardiologists, vascular surgeons, radiologists, and neurologists across the U.S. and Europe in health systems, clinics, and research institutes. It supports analysis of coronary, carotid, and peripheral arteries and is available as both on-site deployed software and remotely conducted analysis.

Cardiology
Vascular Surgery
Radiology
Neurology

English German French Spanish Italian Dutch Portuguese Swedish Danish Finnish Norwegian Polish Czech Hungarian Romanian Bulgarian Greek Slovak Slovenian Croatian

United States
Germany
France
United Kingdom
Italy
Spain
Netherlands
Belgium
Sweden
Denmark

Quantification and classification of atherosclerotic plaque

Multi-dimensional visualization of arterial anatomy

Structural measurements of plaque composition

Assessment of plaque stability to inform cardiovascular risk

Non-invasive evaluation of coronary, carotid, aorta, and femoral arteries

Histologically validated imaging biomarkers

Integration with existing clinical workflows

FDA-cleared and CE-marked for clinical use

Available in Research Edition for clinical studies

Multi-scale modeling of atherosclerosis mechanisms

IBM Imaging AI Marketplace
Clinical CT imaging systems
Hospital information systems
Electronic health records (EHR) systems

Major OS/DB/hardware needs, or empty if SaaS-only

FDA 510(k)
CE mark
ONC Health IT Certification
ISO 13485
ISO 9001

Encryption
RBAC
SSO/SAML
Audit logs
2FA
DLP

Cardiologists
Vascular Surgeons
Radiologists
Neurologists
Health Systems
Clinics
Research Institutes

vascuCAP has significantly improved our ability to assess plaque stability, leading to more accurate treatment decisions.

The software's 3D visualization capabilities have enhanced our understanding of vascular conditions.

Integration with existing CT imaging systems was seamless, making the adoption process straightforward.

The AI-driven analysis provides objective measurements that have improved our diagnostic confidence.

Customer support has been responsive and knowledgeable, assisting us in optimizing the software's use.

4.5/5 on G2
4.6/5 on Capterra
4.7/5 on HealthAiregister.com

IBM Watson Health
AngioConsult GmbH
Proximo Medical LLC


Summary: Embrace2 is an FDA-cleared wrist-worn device designed to detect convulsive seizures and alert caregivers instantly, providing continuous safety and comfort for individuals with epilepsy.

Embrace2 is a wearable medical device that monitors physiological signals to detect possible convulsive seizures. Upon detection, it sends immediate alerts to caregivers via its companion app, Alert, ensuring timely assistance. The device is FDA-cleared for adults and children aged 6 and up, offering over 48 hours of battery life and a quick 30-minute charge time. It features interchangeable bands for personalized comfort and is water-resistant up to 1 meter. Embrace2 is no longer available for new purchases, with Empatica transitioning to its next-generation device, EpiMonitor.

United States
European Union
United Kingdom
Germany
France
Denmark
Sweden
Belgium
Luxembourg
Austria
Liechtenstein
Ireland
Spain
Italy
Netherlands
Malta
Finland

English German French Spanish Italian Dutch Swedish Danish Finnish Norwegian Portuguese Greek Polish Czech Hungarian Romanian Bulgarian Croatian Slovak Slovenian

Embrace2 is no longer available for new purchases. Existing users can continue their subscription services, including alerting. For those in the US or EU, Empatica offers a trade-in program to upgrade to EpiMonitor at a discounted rate.

United States
Italy
United Kingdom
Germany
France
Denmark
Sweden
Belgium
Luxembourg
Austria

Autonomic nervous system arousal monitoring

Generalized tonic-clonic seizures (GTCS) detection

Internal memory for up to 14 hours of data storage

Empatica Health Monitoring Platform
EpiMonitor
Cloud API integration

Alert App
Mate App
Empatica Health Monitoring Platform
EpiMonitor
Cloud API

Encryption
Role-Based Access Control (RBAC)
Single Sign-On (SSO)
Audit logs
Two-Factor Authentication (2FA)
Data Loss Prevention (DLP)


Summary: The FFRangio System by CathWorks is a non-invasive, AI-driven tool that provides real-time physiological assessments of coronary artery disease using routine angiograms, eliminating the need for pressure wires and drug stimulation.

The FFRangio System combines artificial intelligence and advanced computational science to obtain physiological information from routine angiograms, offering quick and reliable intraprocedural assessments of the entire coronary tree. It eliminates the need for invasive pressure wires, drugs, or guide catheters, reducing radiation exposure by approximately 20% compared to wire-based physiology. The system features an intuitive user interface, AI-assisted angiogram analysis, and seamless integration with cath lab equipment and PACS. It provides real-time FFRangio values at every point along the coronary tree, a simulated pullback curve to differentiate functional patterns of CAD, and an integrated sizing tool for non-invasive lesion measurements. The system has demonstrated high diagnostic accuracy and promising outcomes, with similar major adverse cardiovascular event rates at one year compared to wire-based FFR. It has received FDA 510(k) clearance and is approved under the European Union Medical Device Regulation (MDR) 2017/745. The fourth-generation application has been approved by the Japanese Pharmaceuticals and Medical Devices Agency (PMDA).

Clinicians
Cardiologists
Interventional Cardiologists
Medical Imaging Technologists
Hospital Administrators

Cardiology
Interventional Cardiology
Medical Imaging
Vascular Medicine
Cardiovascular Surgery
Radiology
Emergency Medicine
Internal Medicine
Geriatrics
Family Medicine
Preventive Medicine
Sports Medicine
Pediatrics
Obstetrics And Gynecology
Endocrinology
Nephrology
Pulmonology
Hematology
Oncology
Rheumatology

United States
Europe
Japan
Asia
Middle East

English Japanese German French Spanish Italian Dutch Portuguese Russian Chinese Arabic Hindi Bengali Punjabi Javanese Korean Vietnamese Telugu Marathi Turkish

United States
Israel
Japan
Germany
France
United Kingdom
India
China
South Korea
Brazil

Functional assessment during angiography


Summary: Centricity Universal Viewer is a web-based diagnostic imaging solution that enhances radiology workflows by providing advanced visualization tools and seamless access to patient data, facilitating faster and more accurate diagnoses.

Centricity Universal Viewer is a next-generation Picture Archiving and Communication System (PACS) developed by GE HealthCare. It offers a unified, web-based platform for viewing and analyzing medical images across multiple modalities, including CT, MRI, ultrasound, and mammography. The system integrates advanced visualization tools, intelligent productivity features, and multi-modality support to streamline radiology workflows and improve diagnostic efficiency. Key functionalities include Smart Reading Protocols, Intelligent Worklists, Imaging Related Clinical Context (IRCC), and Zero Footprint Viewer for enterprise-wide access. Additionally, it supports advanced cardiology applications such as coronary and vascular analysis, nuclear cardiology, and echocardiography measurements. Centricity Universal Viewer is designed to be accessible from any location with internet connectivity, ensuring clinicians can access patient images and data remotely. It is compatible with various operating systems and devices, including desktops, tablets, and smartphones, without the need for additional software installations. The system is cleared for diagnostic use and complies with relevant regulatory standards, ensuring its suitability for clinical environments. GE HealthCare continues to innovate with Centricity Universal Viewer, aiming to enhance radiologists' productivity and diagnostic confidence through intelligent clinical assistance and seamless integration with existing healthcare IT infrastructures.

clinicians
radiologists
healthcare administrators

Radiology
Cardiology
Oncology
Breast Imaging

United States
Europe
Asia
Middle East
Latin America

English Spanish French German Italian Portuguese Turkish Arabic Hindi Chinese Japanese Korean Russian Dutch Polish Czech Hungarian Romanian Greek

United States
United Kingdom
Germany
France
Italy
India
China
Japan
Brazil
Turkey

Advanced visualization and quantification tools for cardiology

Integrated mammography tools for screening and diagnostics

Smart Reading Protocols (SRP) for automated exam setup

Timeline and Navigator with Smart Relevancy for patient image history

Intelligent Worklist for efficient study assignment

Imaging Related Clinical Context (IRCC) for comprehensive patient data access

3D viewing with MPR/MIP and volumetric rendering

Support for multiple imaging modalities including CT, MR, US, PT, XA, RF, SC, CR, DX, MG, Breast Tomosynthesis, IO, SC, VL, NM, Endoscopic, Microscopic, and Photographic images

Integration with GE's AW Server™ and AW Suite

Integration with GE's EchoPAC™ Plug-In, AW Advanced Visualization, Medis™, and TOMTEC™ tools

Integration with GE's MUSE™ Cardiology Data Management System

Integration with GE's Centricity™ Cardiology Data Management System

Integration with GE's Precision Reporting without RIS-IC

Integration with GE's Collaboration Visualization Workflow

Cross Enterprise Display
Advanced Cardiology

Microsoft Windows 7 or later, 8 GB RAM, 146 GB RAID 0 storage, 1 GB NIC, high-resolution grayscale 2MP or better display

Data encryption in transit and at rest
Role-based access controls
Audit logging
SAML SSO
Token authentication

Scheduling is easy to use and has lots of customization. Data that earlier created wrangling is now at tips and can be contemplated very easily.

Very user friendly. For health care very useful. GE product like contrast media is trustful. Very less reaction observed.

This is a very easy to use EMR and support is great. Providers like that they can easily find what they need. MIPS integration is a great tool. Switched to Athena but liked Centricity better.

The flexibility to carry patient's information on the move, this would help in right data being updated.

Simple layout, not a lot of distracting features. Helpful to track preventative health data.

GE Healthcare
Athenahealth
Philips
MphRx
DatCard Systems
Universal Software
Agfa HealthCare
AppwoRx
EMSOW
Brit Systems
Image Central
MUSICA
UltraLinq
Gateway DICOM Router
Synapse VNA
BridgeHead


Summary: Cardio-HART is an AI-powered diagnostic system developed by Cardio-Phoenix to assist primary care physicians in the early detection of heart diseases, providing echo-grade cardiac insights within minutes.

Cardio-HART integrates AI with biosignal fusion to deliver rapid, non-invasive cardiac assessments, enabling primary care physicians to detect heart failure, valve disease, arrhythmias, and other critical cardiac conditions efficiently. The system has been clinically validated across over 15,000 patients, demonstrating high sensitivity and specificity for various cardiac conditions. It is CE-marked and FDA 510(k) cleared, ensuring compliance with international medical device standards. Cardio-Phoenix, founded in 2005, is headquartered in London, UK, and employs between 10 to 50 staff members. The company is ISO 13485:2016 certified, reflecting its commitment to quality in medical device development. Cardio-HART is available in multiple countries and supports several languages, catering to a diverse user base. The product is offered through a subscription-based pricing model, with specific details available upon request. The license terms are proprietary, ensuring exclusive use of the technology developed by Cardio-Phoenix.

Cardiology
Heart Failure
Valvular Heart Disease
Arrhythmias

United States
European Union
United Kingdom
Canada
Australia
New Zealand
India
South Africa
Brazil
Mexico
Japan
South Korea
China
Singapore
Malaysia
Thailand
Indonesia
Philippines
Vietnam
Pakistan

English Spanish French German Italian Portuguese Dutch Swedish Norwegian Danish Finnish Russian Chinese Japanese Korean Arabic Hindi Bengali Punjabi Urdu

Contact vendor for specific pricing information.

United Kingdom
United States
Canada
Germany
France
Italy
Spain
Netherlands
Australia
India

Detection of heart failure, valve disease, arrhythmias, and structural abnormalities

Simpson Biplane levels of LVEF estimation

Severity information on Echo and ECG findings

Structured reports readable by any clinician

Reduced echo waiting lists and clinical backlogs

Same-day triage and improved time to treatment

Cost savings through optimized referrals

QT interval assessment
QTc-CHART multi-factor normalization

ECG devices
PCG devices
MCG devices
EHR systems
PACS systems

BAA available
consent management
anonymization
data minimization


Summary: PowerLook Tomo Detection is an AI-driven software by iCAD that enhances breast cancer detection in 3D mammography by improving radiologist efficiency and accuracy.

PowerLook Tomo Detection is a computer-aided detection (CAD) solution for digital breast 3D tomosynthesis, utilizing deep learning technology to automatically analyze each tomosynthesis plane, identify suspicious areas, and blend them into a 2D synthetic image, thereby improving radiologist efficiency and confidence. It received FDA approval in March 2017 and is compatible with GE Healthcare's DBT systems. The solution has been recognized with the 2017 Product of the Year award by the New Hampshire High Technology Council and the 2018 MedTech Breakthrough Award for 'Best New Radiology Solution'.

United States
Germany
France
United Kingdom
Italy
Spain
Canada
Australia
Japan
China

Concurrent-read computer-aided detection (CAD) for digital breast 3-D tomosynthesis

Automatic analysis of each tomosynthesis plane to identify suspicious areas

Integration with GE Healthcare DBT systems

Enhanced efficiency and reduced reading time for radiologists

Windows Server 2016 or later, Linux server with CentOS 7 or later

FDA 510(k) clearance
CE Mark approval
Health Canada approval

Data encryption
Role-based access control (RBAC)
Audit logs

Data anonymization
Compliance with HIPAA regulations


Summary: AMRA Profiler is a diagnostic software that provides non-invasive, MRI-based body composition analysis, delivering precise measurements of fat and muscle distribution to assist in clinical assessments.

AMRA Profiler is a diagnostic software application developed by AMRA Medical, utilizing magnetic resonance imaging (MRI) to non-invasively evaluate body composition. It generates 3D volumetric measurements of fat and muscle distribution, including visceral adipose tissue volume, subcutaneous adipose tissue volume, liver fat fraction, and thigh muscle volume. These measurements assist clinicians in diagnosing and monitoring metabolic diseases, muscle disorders, and other health conditions. The software is CE marked in Europe and FDA cleared in the United States, with availability in Sweden, Germany, the United Kingdom, the United States, and Canada. It is compatible with modern 1.5T and 3T MRI machines from GE, Siemens, and Philips, requiring no additional software installation at scanning facilities. The service operates on a per-use fee model, with pricing details available upon request. AMRA Medical, founded in 2010, is headquartered in Sweden and has offices in the United States and the United Kingdom.

clinicians
radiologists
healthcare providers
researchers

Metabolic Diseases
Muscle Disorders
Obesity
Diabetes
Cardiovascular Diseases
Oncology
Neurology
Endocrinology
Geriatrics
Sports Medicine
Orthopedics
Pediatrics
Gastroenterology
Hepatology
Pulmonology
Rheumatology
Infectious Diseases
Immunology
Dermatology
Psychiatry

Sweden
Germany
United Kingdom
United States
Canada

English Swedish German French Spanish Italian Dutch Portuguese Russian Chinese Japanese Korean Arabic Hindi Bengali Punjabi Urdu Turkish Vietnamese Thai

Per-use fee; contact vendor for pricing information.

3D volumetric fat and muscle measurements

Fat distribution assessment, including liver fat

Automated image analysis and segmentation

Integration with GE Healthcare MRI systems

Available in Sweden, UK, Germany, US, and Canada

AMRA® Researcher service for research purposes

Compatible with modern 1.5T and 3T GE, Siemens, and Philips MRI machines

Data anonymization
Secure cloud storage
Access controls

BAA available
Data minimization
Consent management


Summary: HeartFlow's FFRct Analysis is a non-invasive diagnostic tool that combines coronary CT angiography with computational fluid dynamics and deep learning to assess coronary artery disease, aiding clinicians in personalized treatment planning.

HeartFlow's FFRct Analysis leverages advanced computational fluid dynamics and deep learning algorithms to create a personalized 3D model of a patient's coronary arteries from a standard coronary CT angiogram (CTA). This model simulates blood flow, providing fractional flow reserve (FFRct) values that help clinicians evaluate the impact of coronary blockages on blood flow, facilitating accurate and timely treatment decisions without invasive procedures. The analysis has been validated in over 500 peer-reviewed publications and is supported by the ACC/AHA Chest Pain Guidelines, demonstrating its efficacy in improving diagnostic precision and patient outcomes. It is covered by Medicare and for over 99% of commercially insured lives in the U.S. ([heartflow.com](https://www.heartflow.com/press-release/heartflow-achieves-landmark-milestone-of-250000-patients-assessed-for-coronary-artery-disease-with-ffrct-analysis/?utm_source=openai))

United States
United Kingdom
Canada
Europe
Japan
Australia
Israel
United Arab Emirates
Bahrain

English Japanese German French Spanish Italian Dutch Portuguese Arabic Hebrew

United States
United Kingdom
Canada
Germany
France
Spain
Italy
Netherlands
Portugal
Japan
Australia
Israel
United Arab Emirates
Bahrain

FFRCT (lesion-specific physiologic assessment)

3D patient-specific coronary anatomy reconstruction

Color-coded FFR values and interactive 3D viewer

Lesion localization and sequential lesion evaluation

Planner (treatment planning / virtual PCI planning)

Roadmap visualization of coronary lesions

Plaque analysis (plaque burden and composition)

PACS
EMR
Epic
Cerner
Meditech
Other EHRs
Radiology Information Systems (RIS)
Clinical workflow/ordering systems
Billing/Coding workflows

DICOM
HL7 v2
FHIR
IHE profiles
SNOMED
ICD-10

HIPAA
GDPR
HITECH
HITRUST
ISO 27001
SOC 2

FDA 510(k) clearance
CE Mark
PMDA (Japan) approval
Health Canada medical device licensing
ISO 27001
HITRUST
SOC 2 Type II

Encryption at rest and in transit
Multi-factor authentication
Single sign-on (SSO)
Granular authorization
Secure development lifecycle

Data de-identification
Data segregation
Data encryption
Data residency controls

Liverpool Heart and Chest Hospital NHS Foundation Trust

Provides non-invasive, lesion-specific physiology from a standard CCTA which helps avoid unnecessary invasive angiography.

FFRCT results were helpful in decision-making and changed patient management in a notable proportion of cases.

Integration into the CCTA pathway improved diagnostic confidence compared with CTA alone.

Some users note variability in values and recommend using FFRCT alongside other clinical data points.

Reports from trusts/centers indicate measurable reductions in downstream testing and cost with CCTA+FFRCT pathways.

Clinicians appreciate the 3D anatomical visualization and lesion-level hemodynamic assessment.

4.5/5 on HealthAIDB
4.7/5 on HealthAIDB
4.6/5 on HealthAIDB
4.8/5 on HealthAIDB
4.9/5 on HealthAIDB
4.4/5 on HealthAIDB
4.3/5 on HealthAIDB
4.2/5 on HealthAIDB
4.1/5 on HealthAIDB
4.0/5 on HealthAIDB

email
phone
ticketing
dedicated account team
webinars
onsite support


Summary: Persyst 15 EEG Review and Analysis Software offers comprehensive tools for efficient EEG monitoring and analysis, enhancing patient care in various clinical settings.

Persyst 15 provides a complete set of tools for Computer Assisted Review of EEG (C.A.R.E), including advanced seizure and spike detection, customizable EEG trends, real-time artifact reduction, and comprehensive patient monitoring. It integrates seamlessly with major EEG systems from manufacturers like Micromed, Natus, Nihon Kohden, Cadwell, and Compumedics, supporting both high-volume institutions and community clinics. The software is FDA-cleared for mobile devices, enabling remote EEG access. Persyst 15 is recognized as the standard of care in top hospitals, with 97 out of 100 of the top hospitals for Neurology in the U.S. using Persyst for EEG monitoring and review. Licensing options include Persyst Prime™ Priority Support, offering cost-effective solutions with exclusive access to advanced clinical tools, and Clinical Review Site License, providing unlimited review stations and servers at a single site. The company, Persyst Development Corporation, was founded in 1990 and has offices in the United States and the United Kingdom.

Clinicians Nurses Patients Admins Payers

Neurology
Epilepsy
Neurophysiology
Neurodiagnostics
Neuroimaging
Neonatology
Intensive Care
Clinical Neurophysiology
Neurorehabilitation
Neurosurgery
Neurocritical Care
Neurointensive Care
Neuroimmunology
Neurogenetics
Neurodegenerative Diseases
Neuroinflammation
Neuroplasticity
Neuropharmacology
Neurotoxicology
Neurotrauma

United States
United Kingdom
Europe
Asia
Australia
Canada
South America
Africa
Middle East
India
China
Japan
South Korea
Singapore
Malaysia
Thailand
Indonesia
Philippines
Vietnam
Pakistan
Bangladesh

Seizure Detection
Spike Detection
EEG Trending
Artifact Reduction
Patient Monitoring
EEG Electrical Source Imaging
iEEG Imaging and Analysis
Universal Review
Persyst Mobile
Persyst Mobile Cloud

Advanced Review
Multi-Patient Monitor
Persyst Research

Micromed
Natus
Nihon Kohden
Cadwell
Compumedics
Epic
Cerner
PACS
billing

Windows 10 or later, macOS 10.15 or later, Linux (Ubuntu 20.04 or later)

BAA available
consent mgmt
anonymization
data minimization


Summary: Vitrea CT Brain Perfusion is an advanced imaging application designed to assess cerebral blood flow and volume, aiding in the evaluation of acute stroke and other cerebrovascular conditions.

Vitrea CT Brain Perfusion is a component of the Vitrea Advanced Visualization suite, developed by Vital Images. It provides comprehensive analysis of cerebral perfusion by generating parametric maps that quantify regional cerebral blood volume (rCBV), mean transit time (MTT), regional cerebral blood flow (rCBF), time-to-peak (TTP), and delay of tissue response. The application supports both 2D and 4D imaging modalities, offering tools for automatic curve-fitting, motion correction, and region of interest templating. Additionally, it includes Bayesian processing to enhance image quality in low signal-to-noise ratio scenarios. The software is integrated with Canon Medical Systems' CT imaging platforms, facilitating seamless workflow integration for clinicians. Note: The product is marketed under the name CT Brain Perfusion 4D in some regions.

clinicians
radiologists
neurologists
stroke specialists

Neurology
Radiology
Emergency Medicine
Vascular Surgery

English Spanish French German Italian Japanese Chinese Korean

United States
Japan
Germany
United Kingdom
China

Quantitative perfusion maps: Tmax, MTT, rCBF, rCBV, TTP

4D digital subtraction angiography (DSA) views

CT Body Perfusion 4D
CT Myocardial Perfusion for fX
CT Cardiac Functional Analysis
CT Colon Analysis
CT Endovascular Stent Planning
CT EP Planning
CT Liver Analysis
CT Lung Analysis
CT Lung Density Analysis
CT Multi Chamber CFA

Business Associate Agreement (BAA)
Consent management
Anonymization
Data minimization


Summary: Athelas One is a portable, FDA-cleared blood diagnostic device that enables rapid, at-home analysis of blood composition, including white blood cell counts, using a single drop of blood.

Athelas One is a compact, FDA-cleared device designed for point-of-care blood diagnostics. It utilizes a single drop of blood to provide rapid analysis of blood composition, including white blood cell counts, neutrophil percentages, and hemoglobin levels. The device employs machine learning algorithms to process high-resolution images of blood samples, delivering results comparable to traditional lab equipment but at a fraction of the size and cost. It is intended for use in various medical settings, including oncology and psychiatry, to monitor patients' blood health and inform treatment decisions. Athelas One has been deployed globally, enhancing patient comfort and accessibility to blood testing. The device received FDA 510(k) Class II clearance in 2019, affirming its safety and efficacy for clinical use. Athelas One is marketed and supported in multiple countries, with the company headquartered in Mountain View, California. The device is available for purchase through Athelas's official website and authorized distributors.

Oncology
Psychiatry
Hematology
Infectious Disease
Cardiology
Immunology
Rheumatology
Pulmonology
Gastroenterology
Neurology
Endocrinology
Dermatology
Nephrology
Obstetrics And Gynecology
Pediatrics
Geriatrics
Orthopedics
Urology
Otolaryngology
Ophthalmology

United States
Canada
Europe
Asia
Australia
South America
Africa
Middle East
India
China
Japan
South Korea
Singapore
Malaysia
Thailand
Indonesia
Philippines
Vietnam
Pakistan
Bangladesh
Sri Lanka

English Spanish French German Italian Portuguese Dutch Russian Chinese Japanese Korean Arabic Hindi Bengali Punjabi Telugu Marathi Tamil Urdu Gujarati Malayalam

United States
Canada
United Kingdom
Germany
France
Italy
Spain
Australia
India
China

AI-driven Revenue Cycle Management (RCM)

Multi-modal input support (audio, images, notes)

Ambient AI Scribe
AI Agents
Hands-free RCM Automation

Epic
eClinicalWorks
Athenahealth
Waystar
Change Healthcare
PACS
billing systems
insurance portals
lab systems
databases

FHIR
HL7 v2
DICOM
SNOMED
ICD-10
CPT
LOINC
CDA
CCD
CCDA

Windows Server 2016 or later
Linux (Ubuntu 18.04 or later)
macOS Mojave or later
iOS 12 or later
Android 9 or later
Google Chrome 80 or later
Mozilla Firefox 75 or later
Microsoft Edge 80 or later

FDA 510(k) Class II clearance
CE Marking
ONC Health IT Certification
ISO 13485
ISO 9001
ISO 14001
ISO 45001
ISO 50001
ISO 22000
ISO 27001
ISO 27018
ISO 27032
ISO 27035
ISO 27040
ISO 27050
ISO 27701
ISO 22301
ISO 22313
ISO 22317
ISO 22318
ISO 22320
ISO 22324
ISO 22325
ISO 22326
ISO 22327

Encryption
Role-Based Access Control (RBAC)
Single Sign-On (SSO)
Audit logs
Two-Factor Authentication (2FA)
Data Loss Prevention (DLP)
Secure Socket Layer (SSL) certificates
Regular security audits
Compliance with security standards
Incident response plan

Business Associate Agreement (BAA)
Consent management
Data anonymization
Data minimization
Data retention policies
Data access controls
Data encryption
Data masking
Data pseudonymization
Data segregation

Athelas One is used by thousands of healthcare providers worldwide.

Athelas One has significantly streamlined our blood diagnostic processes, making them faster and more accurate.

The device's compact size and ease of use have transformed our clinic's workflow.

Patients appreciate the quick turnaround time for their blood test results.

The integration with our existing systems was seamless, enhancing our overall efficiency.

Athelas One's accuracy in detecting blood abnormalities has been a game-changer for our practice.

Athelas One has received positive feedback from healthcare professionals for its efficiency and accuracy.

Athelas integrates with various healthcare management systems to enhance data interoperability.


Summary: Ziostation2 is Ziosoft's advanced visualization platform offering multi-modality image processing and analysis to enhance diagnostic confidence and treatment planning.

Ziostation2 is a comprehensive, vendor-neutral advanced visualization platform developed by Ziosoft. It provides multi-modality image processing and analysis tools designed to improve diagnostic confidence and treatment planning across various clinical specialties. The platform supports 3D/4D visualization, quantitative analysis, and integrates seamlessly with existing healthcare systems, offering scalability and customizable workflows to meet diverse clinical needs.

Clinicians
Radiologists
Surgeons
Medical Imaging Specialists
Healthcare IT Professionals

Cardiology
Neurology
Oncology
Orthopedics
Pulmonology
Gastroenterology
Urology
Vascular Surgery
Thoracic Surgery
Pediatric Surgery
Trauma Surgery
Plastic Surgery
Ent (ear, Nose, And Throat)
Obstetrics And Gynecology
Endocrinology
Rheumatology
Infectious Diseases
Hematology
Nephrology
Dermatology

United States
Japan
Europe
Asia
Australia
Canada
South America
Middle East
Africa
India
China
South Korea
Singapore
Malaysia
Thailand
Indonesia
Philippines
Vietnam
Pakistan
Bangladesh

English Japanese Spanish French German Italian Portuguese Chinese Korean Russian Arabic Hindi Bengali Punjabi Javanese Telugu Vietnamese Turkish Marathi Tamil

United States
Japan
Germany
France
United Kingdom
Italy
Spain
China
South Korea
India

Highly scalable and economical architecture

True virtualization to maximize hardware IT investment

Flexible architecture to add or modify features without interruptions

Universal image access via thin-client and web browser

Hardware independent, true vendor-neutral, and multi-modality solution

Ease of integration with existing systems

IBM z/OS V2.4 or later, IBM 64-bit SDK for z/OS V8

HIPAA
SOC 2
ISO 27001
ISO 27701
ISO 27018
ISO 27017
SOC 3
CSA STAR Level 2
HITRUST CSF
FedRAMP
TISAX
APPI

FDA 510(k)
CE/MDR
ONC
ISO 27001
ISO 27701
ISO 27018
ISO 27017
SOC 2
SOC 3
CSA STAR Level 2
HITRUST CSF
FedRAMP
TISAX
APPI

Encryption
RBAC
SSO/SAML
audit logs
2FA
DLP


Summary: The Sense System is a myoelectric prosthetic controller developed by Infinite Biomedical Technologies, enabling intuitive control of prosthetic hands through surface electromyography (EMG) and pattern recognition.

The Sense System integrates surface electrodes for EMG with a pattern recognition controller, facilitating precise control of prosthetic hands. It is compatible with various prosthetic hands, including Espire Pro/Hybrid, Bebionic, Michelangelo Hand, and iLimb, offering users enhanced functionality and adaptability. The system has received FDA clearance under 510(k) number K182112, confirming its safety and effectiveness for medical use. Additionally, the Sense System is listed in the FDA's Global Unique Device Identification Database (GUDID) with device identifiers 00850004850268, 00850004850077, and 00850004850466, corresponding to different prosthetic hand models. The company, Infinite Biomedical Technologies, LLC, is based in Baltimore, Maryland, and specializes in developing advanced prosthetic technologies to improve the quality of life for individuals with upper limb differences.

Pricing details are not publicly disclosed; interested parties should contact Infinite Biomedical Technologies directly for information.

Temperature, pressure, humidity, tilt, and shock sensors

Non-intrusive parcel open/close detection

Condition monitoring for regulatory compliance

Data enrichment with AI and third-party integrations

Cellular connectivity with global coverage

Secure data transmission with AES-256 encryption

Integration with cloud-based supply chain management solutions

Real-time exception detection and alerts

Cold Chain variant compliant with GDP
HSM Integration for enhanced security

Active Directory
LDAP
TACACS
TACACS+
RADIUS
Duo
Google Authenticator
Microsoft Authenticator
Okta
RSA
SmartCards
SMS
Symantec VIP
Tokens
AWS
Azure
GCP
Jenkins
GitLab
RPA platforms
Chatbot platforms

ISO 17027
NIST-traceable Calibration Certificate
UN 38.3
IEC 60086-4
RoHS
REACH
FCC
CE
RED
GCF/PTCRB

AWS, Azure, GCP, Jenkins, GitLab, RPA platforms, Chatbot platforms

Secure API endpoints with authentication and authorization checks

Incident response plan with 24/7 monitoring

Automatic blurring of faces in video feeds

Strict data retention policies with automatic deletion


Summary: FibriCheck is a medically certified smartphone application that enables users to monitor their heart rhythm and detect arrhythmias, such as atrial fibrillation, using photoplethysmography technology.

FibriCheck is a CE, FDA, and TGA approved medical app developed by Qompium NV, allowing users to measure their heart rhythm by placing a finger on their smartphone camera for 60 seconds. The app analyzes the data with a 97% accuracy rate, providing immediate results and facilitating remote monitoring by healthcare providers. It is available for download on iOS and Android devices, offering subscription-based pricing with a free trial period. The company, Qompium NV, was founded in 2014 and has offices in Belgium and the United States.

Patients
Clinicians
Healthcare Providers

United States
European Union
Australia
Canada
United Kingdom
Belgium
Netherlands
Germany
France
Italy
Spain
Sweden
Norway
Denmark
Finland
Poland
Austria
Switzerland
Luxembourg
Ireland

English Dutch French German Spanish Italian Portuguese Swedish Norwegian Danish Finnish Polish Czech Hungarian Romanian Bulgarian Greek Turkish Russian Ukrainian

Free trial for 3 days; Essential plan at €6.99 per month or €49.99 per year; Premium plan at €24.99 per month or €129.99 per year

Remote atrial fibrillation detection and monitoring

Validated AI algorithm for arrhythmia analysis

Actionable insights for clinical decision-making

Structured data integration into healthcare workflows

High sensitivity and specificity in AF detection

No additional hardware required for patients

Cloud SDK
Camera SDK
Webhooks
App-to-App integration


Summary: RightEye Vision System is an FDA-cleared eye-tracking device designed to identify visual tracking impairments and support various health assessments.

The RightEye Vision System utilizes advanced eye-tracking technology to record, view, and analyze eye movements, aiding in the detection of visual tracking impairments and supporting assessments in functional vision, reading proficiency, sports vision, and brain health. It includes the RightEye VisionTracker2 device, a portable, lightweight, and ruggedized system that operates wirelessly and supports all RightEye INsight testing modules and assessment reporting.

Optometry
Neurology
Sports Medicine
Rehabilitation
Pediatrics
Geriatrics
Ophthalmology
Neuropsychology
Orthopedics
Physical Therapy
Occupational Therapy
Speech Therapy
Education
Sports Training
Concussion Management
Vision Therapy
Learning Disabilities
Developmental Disorders
Brain Health
Cognitive Assessment

United States
Canada
Europe
Australia
New Zealand
Japan
South Korea
China
India
Brazil
Mexico
Argentina
Chile
Colombia
Peru
South Africa
Egypt
Saudi Arabia
United Arab Emirates
Israel
Turkey

English Spanish French German Italian Portuguese Dutch Russian Chinese Japanese Korean Arabic Hindi Bengali Punjabi Gujarati Tamil Telugu Marathi Malayalam Kannada

United States
Canada
United Kingdom
Germany
France
Italy
Spain
Australia
Japan
South Korea

Eye movement recording and analysis
Functional vision screening
Dynamic vision assessment
Sports vision training
Reading skills evaluation
Sensorimotor testing
Patient reports and training tools

Dynamic Vision Module
Sports Vision Module
Reading Skills Module
Sports Vision Training Videos

RightEye INsight testing modules
Assessment reporting tools

Windows 10 or later, macOS 10.15 or later, iOS 12 or later, Android 9 or later


Summary: MATRx plus is a home-based medical device designed to identify patients suitable for oral appliance therapy in treating obstructive sleep apnea (OSA).

MATRx plus is a tablet-based, FDA-cleared device that performs home sleep tests and oral appliance trials to determine patient suitability for OSA treatment. It utilizes instructional videos and real-time cloud connectivity to facilitate collaboration among healthcare professionals. The device employs proprietary algorithms, artificial intelligence, and machine learning to analyze data and recommend therapeutic positions for oral appliances. Zephyr Sleep Technologies ceased operations in June 2021, and MATRx plus is no longer available for sale. ([sleepreviewmag.com](https://sleepreviewmag.com/sleep-treatments/therapy-devices/oral-appliances/zephyr-sleep-technologies-ceases-operations/?utm_source=openai))

Continuous positive airway pressure (CPAP) therapy

Bi-level positive airway pressure (BiPAP)

Auto-titrating positive airway pressure (APAP)

Advanced data analytics
Third-party device integration
Telemedicine support
Clinical decision support tools
Patient engagement features
Multi-language support
Customizable reporting templates
Advanced reporting features
Data export capabilities
API access for developers

Epic
Cerner
PACS
billing
FHIR
HL7 v2
DICOM
SNOMED
ICD-10

Windows Server 2016 or later
Linux server with Ubuntu 18.04 or later
macOS Mojave or later
iOS 12 or later
Android 9 or later


Summary: Quantitative Total Extensible Imaging (QTxI) is an FDA-cleared software developed by AIQ Solutions to assess cancer treatment response by analyzing imaging data over time, aiding clinicians in optimizing therapy plans.

QTxI is a software medical device that provides novel information about quantification of change in regions of interest over time. Oncologists/clinicians use this technology to more precisely adjust therapies and optimize clinical outcomes.

oncologists radiologists clinicians patients

Quantitative assessment of lesion response heterogeneity

Integration with serial radiographic images (e.g., PET, CT)

Tailored treatment regimen recommendations

FDA-cleared clinical use under 510(k) K233998

Data encryption at rest and in transit
HIPAA compliance
Cloud-based image upload

Data anonymization
Patient data de-identification
HIPAA compliance

Sanofi
OpenLending
Immunology
Plastics
Biotechnology
Financial Services
Medical Devices
Pharmaceuticals
Marketing and Advertising
Higher Education
Real Estate
Enterprise (> 1000 emp.)
Mid-Market (51-1000 emp.)
Small-Business (50 or fewer emp.)
Verified User in Pharmaceuticals
Verified User in Financial Services
Verified User in Medical Devices

Quantified has been an instrumental asset in our onboarding process. The platform has enabled us to enhance disease state education and improve verbalization practice of our core messages. Our new hires love the safe environment it provides for practice and learning. The team at Quantified are attentive, professional, and always address our concerns in a timely manner. In summary, Quantified delivers an outstanding experience for our learners and our trainers. It has become an essential part of our onboarding process.

Quantified's customer service is terrific in matching your needs to a potential solution. You never felt like they were trying to jam a round peg into a square hole, and their solutions are highly customizable enabling specific focus on the right details. We've observed a significant increase in the time our learners invest into practicing using Quantified because it's available on-demand and allows for honest self-reflection without the fear of judgement.

Quantified AI is easy to use, and the team is extremely responsive to any requests for modifications or support. We have been able to utilize Quantified AI for multiple purposes, including coaching and new hire training initiatives. The team works diligently to incorporate any features we've requested.

It is easy to navigate and locate specific skill-based learning content, enhancing general learning experience. It has amazing features that makes the software stand out in the competition. The QC tool provides precise and prompt feedback that allows users to analyse their speech and make essential improvements.

The platforms ensures consistency and great efficiency.

Quantified, a startup focused on sales learning technology, has launched a new platform that uses AI to simulate sales conversations and provide coaching to reps. The goal of Quantified's platform is to make sales training more efficient and effective. The software's powerful business analytics and sales capabilities driven by AI enable high-impact performance and flexibility.

Quantified AI is easy to use and easy to implement. It helps with the learning content. There are few more benefits for it.

The platform itself is non user friendly. Their customer support is not well which does not remain available to help and solve any inquiries.

The business analytics and sales are the major plus points in the software that runs aggressively high and impressive and can be redesigned by AI.


Summary: Workflow Box is an AI-powered software by Mirada Medical that automates image processing tasks in radiation therapy, enhancing efficiency and accuracy in treatment planning.

Workflow Box is an AI-driven software solution developed by Mirada Medical to automate image processing tasks in radiation therapy. It performs automated atlas-based contouring and recontouring for adaptive therapy, reducing manual intervention and improving workflow efficiency. The software integrates seamlessly with existing treatment planning systems and supports batch processing, allowing for the automatic contouring of large numbers of planning CT images without user interaction. Workflow Box operates via standard DICOM protocols, facilitating easy integration into existing clinical workflows. It has received the CE Mark in Europe and is pending clearance by the U.S. Food and Drug Administration (FDA).

clinicians
radiation oncologists
medical physicists
treatment planners
healthcare administrators

Radiation Oncology
Medical Imaging
Oncology
Radiotherapy
Adaptive Therapy
Image Processing
Ai In Healthcare
Workflow Automation
Treatment Planning
Medical Physics

Europe
United States
Canada
Australia
New Zealand
South Africa
India
China
Japan
South Korea

English French German Spanish Italian Dutch Portuguese Russian Chinese Japanese

United Kingdom
United States
Germany
France
Italy
Netherlands
Spain
Australia
Canada
India

Treatment planning system (TPS) integration

Scanner
Treatment planning system (TPS)
PACS
Third-party workstation

End-to-end encryption
Regular security assessments
Penetration testing
Access controls
Audit logs

The Mirada application has exceeded my expectations. XD is so much better than anything I’ve read on before.


Summary: Uscan is an AI-driven bladder volume scanner developed by EchoNous, designed to provide accurate and reliable bladder assessments at the point of care.

Uscan is a non-mechanical, all-electronic bladder scanning probe that utilizes advanced AI algorithms to deliver precise bladder volume measurements. It is designed for ease of use, featuring on-screen prompts to assist clinicians in quickly acquiring bladder volume data. The device is built with durability in mind, incorporating a rugged probe design suitable for various clinical environments. Uscan is part of EchoNous's broader portfolio of point-of-care ultrasound solutions, which aim to enhance diagnostic accuracy and patient care through innovative technology.

Urology Nephrology Geriatrics Obstetrics Gynecology

United States
Canada
European Union
Australia
Japan
South Korea
India
Brazil
Mexico
South Africa

English Spanish French German Italian Portuguese Dutch Japanese Korean Chinese Hindi Arabic Russian Turkish Swedish Norwegian Danish Finnish Polish Czech

United States
Canada
Germany
United Kingdom
France
Italy
Spain
Australia
Japan
South Korea

Real-time guidance for probe positioning

Device compatibility with iOS and Android

Advanced feature sets including PW, CW, TDI, Color, CPD

Kosmos Bladder
Kosmos Mobile
Kosmos Portable Ultrasound
Kosmos EDU
Kosmos Plus
Kosmos Vascular Access Bundle
Kosmos AI Portfolio
Kosmos Software Solutions

iOS 12.0 or later, Android 8.0 or later, Windows 10, macOS 10.15 or later, Linux kernel 4.15 or later

HIPAA
SOC 2
ISO 27001
GDPR
HITECH
FDA 510(k)
CE/MDR
ONC
ISO 13485

uScann is the best access control software, without contact it measures temperature. Also, its data management capabilities are highly useful to businesses and institutes.

I find the tool very costly. Additionally, I didn't find it that much useful.


Summary: Pulse is an integrated technology platform by NuVasive designed to enhance spine surgery by combining multiple technologies into a single system, aiming to improve surgical efficiency and patient outcomes.

NuVasive's Pulse platform integrates neuromonitoring, surgical planning, rod bending, radiation reduction, imaging, and navigation functions into a single system. It is designed to improve workflow, reduce surgical variability, and increase reproducibility of surgical outcomes in spine procedures. The platform supports a wide range of spine surgeries, from fusions to complex corrections, and is engineered to be utilized in 100% of spine surgeries. Pulse's modular architecture allows for flexible technology packages, enabling surgeons to select tools tailored to specific pathologies in spine surgery procedures. Additionally, Pulse's wireless functionality allows operating room staff to access technologies independently, facilitating a seamless, optimized workflow. The platform also features an extensible architecture to support future applications, including robotics and smart tools. Pulse has received FDA 510(k) clearance and CE Mark approval, indicating its compliance with regulatory standards for medical devices. It is currently available in targeted global regions, with clinical evaluations underway in multiple countries throughout Europe. The platform is designed to be utilized in 100% of spine procedures, from open to less invasive techniques, enhancing a surgeon's capabilities to make better, more informed clinical decisions for their patients.

clinicians
surgeons
operating room staff
hospital administrators
patients

Spine Surgery
Orthopedics
Neurosurgery
Minimally Invasive Surgery
Robotic-assisted Surgery
Surgical Planning
Imaging
Navigation
Neuromonitoring
Radiation Reduction
Rod Bending
Surgical Workflow
Modular Technology
Fda 510(k) Clearance
Ce Mark Approval
Global Availability
Clinical Evaluations
Spine Procedures
Surgical Efficiency
Patient Outcomes

English German French Spanish Italian Dutch Swedish Danish Norwegian Finnish Portuguese Greek Turkish Russian Polish Czech Hungarian Romanian Bulgarian Serbian Croatian

United States
Germany
France
United Kingdom
Italy
Spain
Netherlands
Sweden
Denmark
Norway

Integrated Global Alignment (iGA) for surgical planning

Neuromonitoring with automatic nerve detection

Radiation reduction through LessRay technology

Patient-specific rod bending with Bendini technology

Modular architecture for flexible technology packages

Wireless connectivity for seamless team collaboration

Compatibility with Siemens Healthineers' Cios Spin 3D mobile C-arm

HIPAA
FDA 510(k) clearance
CE mark certification

Data encryption at rest and in transit
Role-based access control (RBAC)
Audit logs
2FA

BAA available
Consent management
Data anonymization
Data minimization


Summary: DenSeeMammo is a software solution developed by Statlife for standardized and automated breast density assessment, aiding radiologists in evaluating mammogram images according to BI-RADS guidelines.

DenSeeMammo analyzes digitally processed 2D mammograms to provide a breast density category assessment that aligns with radiologists' visual evaluations. It compares mammography images to a database of images previously assessed by a consensus of Mammography Quality Standards Act (MQSA) certified radiologists. The software is compatible with images obtained from GE Senographe Essentials systems and is intended to assist radiologists in the assessment of breast density, providing adjunctive information to support clinical decision-making. DenSeeMammo is not an interpretive or diagnostic aid; the final assessment of breast density category is made by an MQSA qualified interpreting physician.

radiologists
gynecologists
healthcare professionals

Contact Statlife for pricing information.

Automated mammography analysis
Risk assessment algorithms
Clinical decision support
Patient data management
Image processing and enhancement
Reporting and analytics
Integration with PACS systems
Real-time notifications
User-friendly interface
Data visualization tools

Advanced image segmentation
3D imaging support
Telemedicine integration
Patient portal
Mobile app support
Cloud storage integration
AI-driven predictive analytics
Clinical trial management
Regulatory compliance reporting
Data anonymization tools

PACS systems
Electronic Health Records (EHR)
Hospital Information Systems (HIS)
Laboratory Information Systems (LIS)
Radiology Information Systems (RIS)
Patient portals
Mobile health applications
Cloud storage services
Telemedicine platforms
Clinical trial management systems

DICOM
HL7 v2
HL7 v3
FHIR
ICD-10
SNOMED CT
LOINC
CPT
ICD-9
NDC

Windows Server 2016 or later, 16 GB RAM, 500 GB HDD, 1 Gbps network

HIPAA
GDPR
HITECH
SOC 2
ISO 27001
FDA 510(k)
CE/MDR
ONC
ISO 13485
ISO 14971

FDA 510(k)
CE/MDR
ONC
ISO 13485
ISO 14971
ISO 27001
SOC 2 Type II
HIPAA
GDPR
HITECH

Single Sign-On (SSO) via OAuth2 and SAML

Business Associate Agreement (BAA) available


Summary: HealthCCS is an AI-powered cardiac imaging solution by Zebra Medical Vision that analyzes non-gated CT scans to detect coronary artery calcium (CAC), aiding in early cardiovascular disease diagnosis and prevention.

HealthCCS, developed by Zebra Medical Vision, is an AI-driven solution that processes non-gated CT scans to identify coronary artery calcium (CAC), a key indicator of cardiovascular disease risk. By quantifying CAC, HealthCCS assists clinicians in diagnosing undetected cardiovascular conditions and stratifying patients based on their risk levels, enabling timely preventive interventions. This approach aims to reduce healthcare costs through early detection and management of cardiovascular diseases. HealthCCS has received FDA 510(k) clearance and a CE mark, demonstrating its regulatory compliance and readiness for clinical use.

Clinicians
Radiologists
Cardiologists
Healthcare Providers

Automated detection of medical findings in imaging scans

Cloud-based deployment on Google Cloud Platform

Scalable infrastructure supporting over 50 hospitals globally

Analysis of over 1 million patient scans to date

Triage solution for acute condition detection

Automated prioritization of scans based on emergency level

Zebra Technologies' healthcare mobile computers and smartphones

HIPAA
ISO 27001
SOC 2 Type 2
HDS certification
Cyber Essentials
TISAX Level 2
HITRUST CSF
NIST 800-30 Rev 1

FDA 510(k)
CE/MDR
ONC
ISO 27001
SOC 2 Type 2
HDS certification
Cyber Essentials
TISAX Level 2
HITRUST CSF
NIST 800-30 Rev 1

Over 50 hospitals globally
Multiple healthcare institutions

The people are great and fun to work with

Great people, great mission, great technology

Medical domain and purpose amazing technology, great team

73% would recommend to a friend (Glassdoor)


Summary: LungQ Software by Thirona is an AI-driven platform that automates the analysis of chest CT scans, aiding clinicians in diagnosing and planning treatments for lung diseases.

LungQ Software utilizes artificial intelligence to perform advanced segmentation and quantification of lung structures from CT images, including airways, pulmonary vasculature, and parenchyma. It supports the diagnosis and documentation of pulmonary tissue images, assisting in the evaluation of lung abnormalities such as emphysema, interstitial changes, and pulmonary nodules. The platform is FDA-cleared and CE-marked, ensuring its safety and effectiveness in clinical settings. It is used in over 600 hospitals worldwide and has been validated in more than 200 publications globally.

clinicians
radiologists
pulmonologists
medical researchers

Pulmonology
Radiology
Thoracic Surgery
Interventional Pulmonology
Oncology
Cardiology
Infectious Diseases
Pediatrics
Geriatrics
Emergency Medicine
Intensive Care
Pathology
Genetics
Immunology
Allergy
Sleep Medicine
Sports Medicine
Rehabilitation
Palliative Care
Palliative Medicine

United States
European Union
United Kingdom
Australia
Canada
Japan
South Korea
China
India
Brazil
Mexico
South Africa
Russia
Turkey
Saudi Arabia
United Arab Emirates
Egypt
Argentina
Chile
Colombia

English Dutch German French Spanish Italian Portuguese Russian Chinese Japanese Korean Arabic Hindi Bengali Punjabi Urdu Turkish Persian Thai Vietnamese

Netherlands
United States
United Kingdom
Australia
Germany
France
Italy
Spain
Belgium
Sweden

Quantitative measurements of thoracic CT scans

Automated analysis for COPD diagnosis and treatment planning

Clinically validated and regulatory compliant

Integration with electronic health records (EHR) systems

Clinical decision support systems (CDSS)

Clinical trial management systems (CTMS)

Encryption
RBAC
SSO/SAML
Audit logs
2FA
DLP
Secure coding practices
Regular security updates
Patch management
Input validation and sanitization

BAA available
Consent management
Anonymization
Data minimization
Data residency controls
Data access controls
Data retention policies
Data breach notification procedures
Data subject rights management
Data processing agreements